Sharabi-Nov, A.; Premru Sršen, T.; Kumer, K.; Fabjan Vodušek, V.; Fabjan, T.; Tul, N.; Meiri, H.; Nicolaides, K.H.; Osredkar, J.
Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis. Reprod. Med. 2021, 2, 35-49.
https://doi.org/10.3390/reprodmed2010005
AMA Style
Sharabi-Nov A, Premru Sršen T, Kumer K, Fabjan Vodušek V, Fabjan T, Tul N, Meiri H, Nicolaides KH, Osredkar J.
Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis. Reproductive Medicine. 2021; 2(1):35-49.
https://doi.org/10.3390/reprodmed2010005
Chicago/Turabian Style
Sharabi-Nov, Adi, Tanja Premru Sršen, Kristina Kumer, Vesna Fabjan Vodušek, Teja Fabjan, Nataša Tul, Hamutal Meiri, Kypros H. Nicolaides, and Joško Osredkar.
2021. "Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis" Reproductive Medicine 2, no. 1: 35-49.
https://doi.org/10.3390/reprodmed2010005
APA Style
Sharabi-Nov, A., Premru Sršen, T., Kumer, K., Fabjan Vodušek, V., Fabjan, T., Tul, N., Meiri, H., Nicolaides, K. H., & Osredkar, J.
(2021). Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis. Reproductive Medicine, 2(1), 35-49.
https://doi.org/10.3390/reprodmed2010005
